EAACI High-Level EU Stakeholders Lunch: ‘Working together to progress EU policies for the benefit of allergic patients in Europe’

The EAACI High-Level EU Stakeholders Lunch (June 13th 2016, Vienna) brought together representatives from the EU Institutions, patient advocates, allergy national societies, industry, and EAACI leadership to jointly reflect on collaborations to advance EU policies for the benefit of allergic patients. 
EAACI High Level EU Stakeholders Lunch   vienna congress 2016

Keynote addresses included:
-          Professor Antonella Muraro (President of EAACI) who reiterated that success in tackling the allergy crisis in Europe requires partnerships between all interested stakeholders and continuous collaborations in EU actions at policy level;
-          MEP Sirpa Pietikaïnen (Chair of the European Parliament Interest Group on allergy and asthma) who highlighted the need for comprehensive EU-wide programmes on allergy and asthma building on existing national and regional best practices;
-          Stefan Schreck (European Commission) who reminded that the Commission sees a clear added-value in having all Member States working together on chronic diseases at EU level, and hence will continue supporting such policy dialogue, where allergy and asthma should naturally be included;
-          Professor Sergio Bonini (EMA) who stressed the importance of developing facilitated pathways for marketing authorisations of allergen product and to distinguish between allergen products used for in vivo diagnostics and products for allergen immunotherapy;
-           Michele Antonelli (European Biopharmaceutical Entreprises & Stallergenes Greer) who confirmed the industry’s support to the development of precision medicine (PM) in allergy.

The moderated discussion was then the occasion for participants to hold fruitful discussions with the contribution of patient representatives from EAACI Patient Organisations Committee and EFA.

The 2016 high-level event was a successful step in the further engagement of the EAACI network in a dialogue to foster partnerships and collaboration between EU policy-making bodies and interested stakeholders to address allergy and asthma as part of the EU health and research policy actions.

You can read the full event report here, you can see the event agenda here and all pictures here.
Last updated 01 December 2016
EAACI's EU liaison office in Brussels acts as the contact point for internal and external EAACI EU Affairs relations.
EAACI – EU Liaison Office
Rue du Luxembourg, 22-24
B-1000 Brussels
Tel : +32 (2)2 761 66 83


As the leading European medical society focusing on allergy, EAACI has a key role to play in the formulation of health and research policies at the European level. EAACI activities focus on improving allergy care, fostering allergy research and help strengthen Allergology as a medical specialty.

By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback